Huntington's disease is an inherited neurodegenerative disorder, the cause
of which is unknown. Excitotoxicity, mitochondrial dysfunction and oxidativ
e stress are all likely to contribute to the striatal cell death that occur
s in this disorder. There are accumulating data indicating that under speci
fic circumstances, dopamine, which occurs in high concentrations in the bas
al ganglia, might be neurotoxic. In this article, the current models used t
o study Huntington's disease are reviewed and the recent findings that impl
icate dopamine in the pathophysiology of this progressive disorder are disc
ussed. Although many questions remain unanswered, the dopaminergic system c
ould contribute to striatal vulnerability in Huntington's disease and provi
de a novel avenue for the development of new therapies.